Osivax
ID: 6340574Developer of vaccines to provide broad-spectrum protection against highly mutating respiratory viruses.
6
Funding Rounds
$37.4m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Al******* Le**** |
|
- | - |
| Al******* Le Ve** |
|
- | |
| Fl****** Ni***** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Osivax has raised a total of $37.38m in funding over 6 rounds.
Key Insights:
- Osivax Series B Round, March 2025: $11m
- Osivax Grant (money), July 2020: $1.34m
- Osivax Grant (money), July 2020: $2.21m
- Osivax Series B round, July 2020: $13.27m
- Osivax Series A round, July 2019: $7.14m
- Osivax Seed round, June 2017: $2.41m
Industries
Osivax is active in the following industries: